Fresenius Medical Care AG & Co. KGaA (ETR: FME)‘s stock had its “hold” rating reiterated by investment analysts at Jefferies Group in a note issued to investors on Wednesday, Analyst Ratings.Net reports.
Shares of Fresenius Medical Care AG & Co. KGaA (ETR: FME) traded up 0.43% during mid-day trading on Wednesday, hitting €52.52. Fresenius Medical Care AG & Co. KGaA has a 52 week low of €47.982 and a 52 week high of €60.24. The stock’s 50-day moving average is currently €56.72.
FME has been the subject of a number of other recent research reports. Analysts at Sanford C. Bernstein reiterated an “outperform” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note to investors on Tuesday. They now have a €61.50 ($79.87) price target on the stock. Separately, analysts at M.M. Warburg Investment Research reiterated a “buy” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note to investors on Friday, May 24th. They now have a €61.00 ($79.22) price target on the stock. Finally, analysts at AlphaValue reiterated an “add” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note to investors on Thursday, May 16th. They now have a €64.60 ($83.90) price target on the stock.
Fresenius Medical Care AG & Co KGaA is a Germany-based holding and kidney dialysis company, operating in the fields of dialysis products and dialysis services.
